KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationDepreciation & Amortization (IS)Depreciation ExpenseEBIATLeasesLong-Term Debt RepaymentsMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)
Ratios

Evolent Health (EVH) Depreciation & Amortization (IS) (2016 - 2025)

Historic Depreciation & Amortization (IS) for Evolent Health (EVH) over the last 11 years, with Q3 2025 value amounting to $23.6 million.

  • Evolent Health's Depreciation & Amortization (IS) fell 2049.09% to $23.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $100.1 million, marking a year-over-year decrease of 1564.43%. This contributed to the annual value of $118.4 million for FY2024, which is 408.78% down from last year.
  • Evolent Health's Depreciation & Amortization (IS) amounted to $23.6 million in Q3 2025, which was down 2049.09% from $23.1 million recorded in Q2 2025.
  • Evolent Health's 5-year Depreciation & Amortization (IS) high stood at $32.4 million for Q3 2023, and its period low was $14.9 million during Q3 2021.
  • In the last 5 years, Evolent Health's Depreciation & Amortization (IS) had a median value of $23.6 million in 2025 and averaged $23.1 million.
  • Its Depreciation & Amortization (IS) has fluctuated over the past 5 years, first soared by 11263.9% in 2023, then tumbled by 2252.76% in 2025.
  • Over the past 5 years, Evolent Health's Depreciation & Amortization (IS) (Quarter) stood at $14.9 million in 2021, then soared by 32.62% to $19.8 million in 2022, then surged by 49.65% to $29.6 million in 2023, then fell by 1.03% to $29.3 million in 2024, then decreased by 19.39% to $23.6 million in 2025.
  • Its Depreciation & Amortization (IS) was $23.6 million in Q3 2025, compared to $23.1 million in Q2 2025 and $24.1 million in Q1 2025.